The pharmaceutical industry develops drugs and interventions that benefit society, allowing us to live healthier, happier, more productive, and more fulfilling lives. Between 2000 and 2009, medicines contributed 73% of the 21-month life expectancy increase. Medicines have also led to 83% of survival gains in cancer, and prevented 862,000 deaths since the mid-90s in the United States alone. 

You know the type of healthcare professionals you need to reach. We know who they are and how they engage with information.

You’ll instantly connect to the latest in global medtech developments with industry news, trends, deals, product developments, opinions, analysis, and context behind the headlines and more – all available at your fingertips.

Covering the cosmetics and dietary supplement industries, Rose Sheet is your one-stop shop for regulatory, legislative, legal and commercial news and insights affecting the personal care industry. 

We deliver clear information, analysis, and recommendations to support your commercialization and portfolio strategies.

We help you understand the expected value and associated risks across your drug development portfolio.

We provide customized research and analysis that transforms information on clinical trials, drugs and sites into actionable intelligence for your organization.

Medtrack, the leader in end-to-end reporting on business developments in the biotech and pharma industry, has been integrated into a more powerful commercial strategy solution.

• Looking for a needle in a haystack opportunity?
• Trying to predict the future of drug approvability and commercial success?
• In search of company and deals intelligence to evaluate potential partnerships?

For more than 25 years, Primal Pictures has led the way in bringing premier 3D digital human anatomy solutions to the market for use in education, practice, research, industry, and more. Our pioneering scientific approach has always put quality, accuracy, and detail at the heart of everything we do.

Strategic Transactions, the pioneer in deals intelligence, has been integrated into a more powerful commercial strategy solution.

• Looking for a needle in a haystack opportunity?
• Trying to predict the future of drug approvability and commercial success?
• In search of company and deals intelligence to evaluate potential partnerships?

Using a peer-reviewed methodology that provides robust, unbiased drug phase success rates and timeline metrics by treatment indication, Pharmapremia enables you to make strong, informed decisions about your drug development pipeline.

• Manage portfolio risks
• Analyze success factors
• Create meaningful benchmarks

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

• Prioritize market opportunities
• Identify unmet needs
• Make informed decisions